The following article requires a subscription:



(Format: HTML, PDF)

: A previously healthy 20-year-old man presented with adult Still disease (ASD). He developed life-threatening macrophage activation syndrome (MAS), which was refractory to standard immunosuppression but responded dramatically to the IL-1 receptor antagonist anakinra. Subsequent immunological investigations included assessment of the perforin expression of natural killer (NK) cells and CD8 T cells, which confirmed MAS.

Copyright (C) 2012 Blackwell Publishing Ltd.